Gallbladder problems , including gallstones, have also been associated with GLP-1 therapy, likely related to rapid weight loss and changes in bile composition
If you are breast-feeding or are planning to breast-feed, talk to your doctor before using or continuing to use this medicine. If you have been offered a GLP-1 medicine to treat your diabetes and are making a decision about whether to take it and how this will impact your breastfeeding journey, or if you have been taking one of these medicines whilst breastfeeding, you can contact the Breastfeeding Network Drugs in Breastmilk team to discuss this
Evidence-Based Complementary and Alternative Medicine 2019(1):3239649 Kim S-M, Kim S-C, Chung I-K, Cheon W-H, Ku S-K (2012) Antioxidant and protective effects of Bupleurum falcatum on the L-thyroxine-induced hyperthyroidism in rats
Light movement helps disperse the injection and may prevent soreness.
[7] In STEP-4 (N=803), participants who continued semaglutide after a 20-week run-in maintained or further reduced their weight, while those who switched to placebo regained 6.9 percentage points of body weight by week 68
A recent meta-analysis of patients with HFrEF enrolled in the DAPA-HF and EMPEROR-Reduced trials demonstrated a 14% reduction in CV death and a 31% reduction in first hospitalisation for HF, whereas the composite outcome of CV death and HF hospitalisation was reduced by 25%, regardless of the presence or absence of T2D